Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eydie Miller-Ellis

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Ophthalmology. Glaucoma|September 4, 2025
Then and Now: Medical Therapy for GlaucomaEydie Miller-Ellis, Gloria P Fleming
Clinical Ophthalmology (Auckland, N.Z.)|December 28, 2018
Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapyVictoria M Addis, Eydie Miller-Ellis
Medicine|June 15, 2017
Trabectome success factorsConstance O Okeke, Eydie Miller-Ellis, Mario Rojas, et al.
American Journal of Ophthalmology|May 27, 2024
Contributions and Legacies of Selected Black Pioneers in Ophthalmology and Institutional MilestonesMildred M G Olivier, Eydie Miller-Ellis, Claude Cowan, et al.
Journal of Epidemiological Research|January 29, 2016
The role of ophthalmology departments in overcoming health care disparitiesRebecca J Salowe, Prithvi Sankar, Eydie Miller-Ellis, et al.
The British Journal of Ophthalmology|September 22, 2016
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised studyEydie Miller Ellis, Michael S Berlin, Caroline L Ward, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 20, 2026
Efficacy and Safety of Preservative-Free Bimatoprost 0.01% Gel in Patients with Open-Angle Glaucoma and Ocular Hypertension: Results from Two Phase III Randomized TrialsJason Bacharach, Eydie Miller-Ellis, Paul Harasymowycz, et al.
Journal of Glaucoma|September 15, 2025
Safety and Efficacy of a Preservative-Free Bimatoprost 0.01% Ophthalmic Gel: Results From a Phase III Controlled TrialEydie Miller-Ellis, James H Peace, Douglas G Day, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 15, 2006
Automated combined kinetic and static perimetry: an alternative to standard perimetry in patients with neuro-ophthalmic disease and glaucomaStacy L Pineles, Nicholas J Volpe, Eydie Miller-Ellis, et al.
Ophthalmology. Glaucoma|December 22, 2020
Clinical and Economic Burden of Glaucoma by Disease Severity: A United States Claims-Based AnalysisVanessa Shih, Mousam Parekh, Jasjit K Multani, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Ophthalmology. Glaucoma|September 4, 2025
Then and Now: Medical Therapy for GlaucomaEydie Miller-Ellis, Gloria P Fleming
Clinical Ophthalmology (Auckland, N.Z.)|December 28, 2018
Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapyVictoria M Addis, Eydie Miller-Ellis
Medicine|June 15, 2017
Trabectome success factorsConstance O Okeke, Eydie Miller-Ellis, Mario Rojas, et al.
American Journal of Ophthalmology|May 27, 2024
Contributions and Legacies of Selected Black Pioneers in Ophthalmology and Institutional MilestonesMildred M G Olivier, Eydie Miller-Ellis, Claude Cowan, et al.
Journal of Epidemiological Research|January 29, 2016
The role of ophthalmology departments in overcoming health care disparitiesRebecca J Salowe, Prithvi Sankar, Eydie Miller-Ellis, et al.
The British Journal of Ophthalmology|September 22, 2016
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised studyEydie Miller Ellis, Michael S Berlin, Caroline L Ward, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 20, 2026
Efficacy and Safety of Preservative-Free Bimatoprost 0.01% Gel in Patients with Open-Angle Glaucoma and Ocular Hypertension: Results from Two Phase III Randomized TrialsJason Bacharach, Eydie Miller-Ellis, Paul Harasymowycz, et al.
Journal of Glaucoma|September 15, 2025
Safety and Efficacy of a Preservative-Free Bimatoprost 0.01% Ophthalmic Gel: Results From a Phase III Controlled TrialEydie Miller-Ellis, James H Peace, Douglas G Day, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 15, 2006
Automated combined kinetic and static perimetry: an alternative to standard perimetry in patients with neuro-ophthalmic disease and glaucomaStacy L Pineles, Nicholas J Volpe, Eydie Miller-Ellis, et al.
Ophthalmology. Glaucoma|December 22, 2020
Clinical and Economic Burden of Glaucoma by Disease Severity: A United States Claims-Based AnalysisVanessa Shih, Mousam Parekh, Jasjit K Multani, et al.
Pageof 4